Tag: Advocacy
-
RINVOQ Survey
The Common Drug Review (CDR) and Institut national d’excellence en santé et en services sociaux (INESSS) are currently welcoming patients to provide input to patient organizations on the manufacturer’s submission for upadacitinib (Rinvoq) for the treatment of ankylosing spondylitis (AS).Organizations supporting patients living with ankylosing spondylitis (AS) develop these patient input submissions whenever a drug…
-
PsA Roundtable
Do you live with Psoriatic Arthritis (PsA)? A leading pharmaceutical company is holding a patient advisory board to learn more about PsA
-
Join a CSA Support Group, Today!
If you want to talk to someone who understands, we have an ankylosing spondylitis support group for you. Meet local people like you Share in a safe environment Feel supported and connected Join the community that knows what you’re going through Experts agree that taking part in a support group can improve your life. Get…